Medicine’s Rong Xu discusses research findings linking GLP-1 medications to lowered risk of certain cancers

Popular weight-loss and diabetes medications linked to lower risk of some cancers, study finds

CNNRong Xu, a professor of biomedical informatics at the School of Medicine, shared new findings from her research highlighting that GLP-1 medications such as Ozempic and Wegovy may help lower the risk of certain cancers. She noted that the findings provide “preliminary evidence of the potential benefit of GLP-1RAs for cancer prevention in high-risk populations and support further preclinical and clinical studies.”